“The U.S. Supreme Court ruled on Monday that makers of generic drugs already approved by the U.S. Food and Drug Administration cannot be held liable under state law for claims of design defects. In a 5-4 vote, the court ruled for Mutual Pharmaceutical Co, a unit of URL Pharma, owned by Sun Pharmaceutical Industries.”
Related posts:
Why More Retailers Are Accepting Bitcoin
IRS apologizes after seizures hammer small businesses
JPMorgan chief Jamie Dimon negotiates fine amount with U.S.
Students arrested for throwing spitballs, lollipops
Al-Qaida turns tide for rebels in battle for eastern Syria
Court Nixes California's License Revocations For Tax-Debtors
Will bourbon help Kentucky swallow Obamacare?
Ex-CIA official to ask Italy for pardon for illegal U.S. 'extraordinary rendition'
Family of Woman Who Led Cops on Capitol Car Chase Suing Police
Hospital doctors join thousands protesting Greece’s austerity layoffs
Web inventor warns governments: Internet has no off switch
French president promises to keep ban on Monsanto GMO corn despite court ruling
Syria opposition ‘disappointed’ but thinks Congress will OK strike
Goodbye Switzerland, Hello Bitcoins
US Secret Service seeks Twitter sarcasm detector